These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 20551621)

  • 1. TLR9 signaling failure renders Peyer's patch regulatory B cells unresponsive to stimulation with CpG oligodeoxynucleotides.
    Booth JS; Arsenault R; Napper S; Griebel PJ; Potter AA; Babiuk LA; Mutwiri GK
    J Innate Immun; 2010; 2(5):483-94. PubMed ID: 20551621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel B regs down-regulate TLR9-induced cytokine responses in sheep Peyer's patches.
    Booth J; Jimbo S; Mutwiri G
    Vet Immunol Immunopathol; 2012 Jul; 148(1-2):157-60. PubMed ID: 21596445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the existence of regulatory and effector B cell populations in Peyer's patches of sheep.
    Jimbo S; Griebel PJ; Townsend H; Babiuk LA; Mutwiri G
    Vet Immunol Immunopathol; 2016 Jun; 174():26-34. PubMed ID: 27185260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel regulatory B-cell population in sheep Peyer's patches spontaneously secretes IL-10 and downregulates TLR9-induced IFNalpha responses.
    Booth JS; Griebel PJ; Babiuk LA; Mutwiri GK
    Mucosal Immunol; 2009 May; 2(3):265-75. PubMed ID: 19262501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides.
    Gantner F; Hermann P; Nakashima K; Matsukawa S; Sakai K; Bacon KB
    Eur J Immunol; 2003 Jun; 33(6):1576-85. PubMed ID: 12778475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-10 secreting CD21⁺ B cells are present in jejunal Peyer's patches of sheep during fetal development.
    Jimbo S; Griebel PJ; Babiuk L; Mutwiri G
    Cell Tissue Res; 2014 May; 356(2):417-25. PubMed ID: 24705583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
    Vollmer J; Weeratna RD; Jurk M; Davis HL; Schetter C; Wüllner M; Wader T; Liu M; Kritzler A; Krieg AM
    J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
    Merlo A; Calcaterra C; Mènard S; Balsari A
    J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor 2 suppresses Toll-like receptor 9 responses in Peyer's patch dendritic cells.
    Kotaki R; Wajima S; Shiokawa A; Hachimura S
    Immunobiology; 2015 Jun; 220(6):734-43. PubMed ID: 25638261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium.
    Pedersen G; Andresen L; Matthiessen MW; Rask-Madsen J; Brynskov J
    Clin Exp Immunol; 2005 Aug; 141(2):298-306. PubMed ID: 15996194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Toll-like receptor 9 in cpG oligodeoxynucleotides-induced species-specific immune responses].
    Li N; Fan XG; Tang SE; Zhu C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 30(5):533-5. PubMed ID: 16320582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional cell surface expression of toll-like receptor 9 promotes cell proliferation and survival in human hepatocellular carcinomas.
    Tanaka J; Sugimoto K; Shiraki K; Tameda M; Kusagawa S; Nojiri K; Beppu T; Yoneda K; Yamamoto N; Uchida K; Kojima T; Takei Y
    Int J Oncol; 2010 Oct; 37(4):805-14. PubMed ID: 20811701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat shock up-regulates TLR9 expression in human B cells through activation of ERK and NF-kappaB signal pathways.
    Chen W; Wang J; An H; Zhou J; Zhang L; Cao X
    Immunol Lett; 2005 Apr; 98(1):153-9. PubMed ID: 15790521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chicken TLR21 acts as a functional homologue to mammalian TLR9 in the recognition of CpG oligodeoxynucleotides.
    Brownlie R; Zhu J; Allan B; Mutwiri GK; Babiuk LA; Potter A; Griebel P
    Mol Immunol; 2009 Sep; 46(15):3163-70. PubMed ID: 19573927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential contribution of osteoclast- and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis.
    Amcheslavsky A; Hemmi H; Akira S; Bar-Shavit Z
    J Bone Miner Res; 2005 Sep; 20(9):1692-9. PubMed ID: 16059640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 9 mediates CpG-DNA signaling.
    Chuang TH; Lee J; Kline L; Mathison JC; Ulevitch RJ
    J Leukoc Biol; 2002 Mar; 71(3):538-44. PubMed ID: 11867692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor 9 agonists promote IL-8 and TGF-beta1 production via activation of nuclear factor kappaB in PC-3 cells.
    Di JM; Pang J; Pu XY; Zhang Y; Liu XP; Fang YQ; Ruan XX; Gao X
    Cancer Genet Cytogenet; 2009 Jul; 192(2):60-7. PubMed ID: 19596255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG-oligodeoxynucleotide inhibits Smad-dependent bone morphogenetic protein signaling: effects on myeloma cell apoptosis and in vitro osteoblastogenesis.
    Nørgaard NN; Holien T; Jönsson S; Hella H; Espevik T; Sundan A; Standal T
    J Immunol; 2010 Sep; 185(6):3131-9. PubMed ID: 20702733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bovine toll-like receptor 9: a comparative analysis of molecular structure, function and expression.
    Griebel PJ; Brownlie R; Manuja A; Nichani A; Mookherjee N; Popowych Y; Mutwiri G; Hecker R; Babiuk LA
    Vet Immunol Immunopathol; 2005 Oct; 108(1-2):11-6. PubMed ID: 16098606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T lymphocytes that express CD4 and the alpha beta-T cell receptor but lack Thy-1. Preferential localization in Peyer's patches.
    Harriman GR; Lycke NY; Elwood LJ; Strober W
    J Immunol; 1990 Oct; 145(8):2406-14. PubMed ID: 1976693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.